Calix Networks (CALX) Drops 5.77% on January 13

Equities Staff |

Calix Networks (CALX) was one of the Russell 2000's biggest losers for Wednesday January 13 as the stock slid 5.77% to $7.18, a loss of $-0.44 per share. Starting at an opening price of $7.64 a share, the stock traded between $7.17 and $7.72 over the course of the trading day. Volume was 164,502 shares over 1,243 trades, against an average daily volume of 262,070 shares and a total float of 50.81 million.

The losses send Calix Networks down to a market cap of $364.82 million. In the last year, Calix Networks has traded between $10.63 and $6.30, and its 50-day SMA is currently $7.44 and 200-day SMA is $7.85.

Calix, Inc., offers broadband communications access systems and software for fiber- and copper-based network architectures that enable communications service providers, to connect to its residential and business subscribers.

Calix Networks is based out of Petaluma, CA and has some 782 employees. Its CEO is Carl Russo.

For a complete fundamental analysis analysis of Calix Networks, check out Equities.com’s Stock Valuation Analysis report for CALX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…